Related Experiment Videos
Antiphospholipid syndrome: insights from animal models
1Department of Medicine B, Sheba Medical Center, Tel-Hashomer, Israel.
Current Opinion in Hematology
|August 29, 2000
Summary
Animal models are crucial for understanding antiphospholipid syndrome (APS) and testing new therapies. Recent research using these models offers insights into APS pathogenesis and effective treatments for patients.
Area of Science:
- Immunology
- Pathogenesis Research
- Translational Medicine
Background:
- Antiphospholipid syndrome (APS) is a complex autoimmune disorder.
- Animal models are essential tools for studying APS pathogenesis and evaluating potential treatments.
- Induced models offer reliable insights into antiphospholipid antibody pathogenicity.
Purpose of the Study:
- To review recent advancements in animal models of APS.
- To highlight new findings on APS pathogenesis, including reproductive failure, neurological issues, thrombosis, and atherosclerosis.
- To discuss novel therapeutic strategies investigated in experimental APS.
Main Methods:
- Utilizing spontaneous genetic and experimental induced animal models of APS.
- Analyzing recent research reports on APS animal models.
- Evaluating the efficacy of novel therapeutic agents in experimental settings.
Main Results:
- Animal models provide critical insights into the role of antiphospholipid antibodies and beta2-glycoprotein-I in APS manifestations.
- Experimental APS models have shown promise for novel therapies like anti-idiotypes, oral tolerance, and beta2-glycoprotein-I binding peptides.
- Recent studies have deepened the understanding of APS pathogenesis in various clinical contexts.
Conclusions:
- Animal models are indispensable for advancing the understanding and treatment of antiphospholipid syndrome.
- Novel therapeutic approaches tested in animal models represent the first step towards clinical application for APS patients.
- Continued research with APS animal models is vital for developing effective therapies.